Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$15.20
Change (%) Stock is Down 0.1 (0.65%)
Volume403,817
Data as of 04/25/17 3:59 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
04/04/17
Download Documentation Company Update (April)

Recent News

More >>
DateTitle 
04/24/17Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, FinancePrinter Friendly Version
03/28/17Heron Therapeutics to Present at the 16th Annual Needham Healthcare ConferencePrinter Friendly Version
03/13/17Heron Therapeutics to Present at the Oppenheimer 27th Annual Healthcare ConferencePrinter Friendly Version
02/28/17Heron Therapeutics to Present at the 37th Annual Cowen and Company Healthcare ConferencePrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.